Salim Yusuf

309.5k citations
1.3k papers · 157.0k indexed · 76 hit papers · h-index 181
Co-authors
Sonia S. AnandStephanie ÔunpuuHertzel C. GersteinJohn W. EikelboomShamir R. MehtaJohn J.V. McMurrayMarc A. PfefferStuart J. Connolly
Topics
Atrial Fibrillation Management and Outcomes (209 papers)Heart Failure Treatment and Management (193 papers)Blood Pressure and Hypertension Studies (189 papers)
Cited by
Cardiology and Cardiovascular MedicineInternal MedicineEndocrinology, Diabetes and Metabolism
Journals
New England Journal of MedicineThe LancetPhysical Review Letters
Partner nations
CanadaUnited StatesUnited Kingdom

In The Last Decade

Salim Yusuf

1.2k papers receiving 149.4k citations

Hit Papers

Effect of potentially modifiable risk factors ...1985202619982012200420092000200119852.5k5.0k7.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
    2004 8.2k citations Salim Yusuf, Álvaro Avezum et al. profile →
  2. Dabigatran versus Warfarin in Patients with Atrial Fibrillation
    2009 8.0k citations Stuart J. Connolly, Michael D. Ezekowitz et al. profile →
  3. Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
    2000 6.2k citations Salim Yusuf profile →
  4. Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
    2001 4.5k citations Salim Yusuf profile →
  5. Beta blockade during and after myocardial infarction: An overview of the randomized trials
    1985 2.4k citations Salim Yusuf, Peter Sleight et al. profile →
  6. Global Burden of Cardiovascular Diseases
    2001 2.2k citations Salim Yusuf et al. Circulation profile →
  7. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study
    2005 2.1k citations Salim Yusuf et al. profile →
  8. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
    2003 2.0k citations Salim Yusuf, Marc A. Pfeffer et al. profile →
  9. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
    2002 2.0k citations Salim Yusuf et al. profile →
  10. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
    2001 2.0k citations Salim Yusuf et al. profile →
  11. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
    2003 1.8k citations John J.V. McMurray, Jan Östergren et al. profile →
  12. Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study
    2004 1.7k citations Salim Yusuf et al. profile →
  13. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.
    2000 1.7k citations Salim Yusuf et al. profile →
  14. The burden of disease in older people and implications for health policy and practice
    2014 1.5k citations Martin O’Donnell, Salim Yusuf et al. profile →
  15. Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients
    2000 1.4k citations Salim Yusuf profile →
  16. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration
    1994 1.4k citations Salim Yusuf et al. profile →
  17. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial
    2011 1.4k citations Salim Yusuf, Andrzej Budaj et al. profile →
  18. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme
    2003 1.3k citations Marc A. Pfeffer, Karl Swedberg et al. profile →
  19. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.
    1999 1.3k citations Salim Yusuf et al. profile →
  20. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
    2006 1.2k citations Salim Yusuf, Janice Pogue et al. profile →
  21. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial
    2003 1.1k citations Christopher B. Granger, John J.V. McMurray et al. profile →
  22. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
    1990 1.1k citations Salim Yusuf et al. Circulation profile →
  23. Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial
    2001 1.1k citations Johannes F.E. Mann, Salim Yusuf et al. profile →
  24. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients
    2000 1.1k citations Salim Yusuf, Marc A. Pfeffer et al. profile →
  25. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
    2008 1.0k citations Johannes F.E. Mann, Roland E. Schmieder et al. profile →
  26. An overview of randomized trials of rehabilitation with exercise after myocardial infarction.
    1989 1.0k citations Salim Yusuf et al. Circulation profile →
  27. Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes
    2006 981 citations John W. Eikelboom, Salim Yusuf et al. Circulation profile →
  28. Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin
    1988 981 citations Salim Yusuf et al. profile →
  29. Emerging Epidemic of Cardiovascular Disease in Developing Countries
    1998 913 citations Salim Yusuf et al. Circulation profile →
  30. Global Burden of Cardiovascular Diseases
    2001 881 citations Salim Yusuf et al. Circulation profile →
  31. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)
    2000 842 citations Salim Yusuf, Koon Teo et al. profile →
  32. Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
    2011 822 citations John W. Eikelboom, Lars Wallentin et al. Circulation profile →
  33. CHARM IN-VESTIGATORS AND COMMITTEES. EFFECTS OF CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND REDUCED LEFT-VENTRICULAR SYSTOLIC FUNCTION TAKING ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS: THE CHARM-ADDED TRIAL
    2003 794 citations John J.V. McMurray, Jan Östergren et al. profile →
  34. Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events
    2002 783 citations John W. Eikelboom, Salim Yusuf et al. Circulation profile →
  35. Predictors of mortality and morbidity in patients with chronic heart failure
    2005 757 citations Stuart Pocock, Duolao Wang et al. profile →
  36. Red Cell Distribution Width as a Novel Prognostic Marker in Heart Failure
    2007 752 citations Stuart Pocock, John J.V. McMurray et al. profile →
  37. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: A systematic review and meta-analysis of randomized trials
    2008 747 citations Salim Yusuf et al. profile →
  38. Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes
    2006 741 citations Salim Yusuf profile →
  39. Reducing the Global Burden of Cardiovascular Disease, Part 1
    2017 741 citations Koon Teo, Andrew Mente et al. profile →
  40. Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure
    2006 733 citations Marc A. Pfeffer, Karl Swedberg et al. Circulation profile →
  41. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
    2010 728 citations Lars Wallentin, Salim Yusuf et al. profile →
  42. Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence
    1999 727 citations John W. Eikelboom, Eva Lonn et al. profile →
  43. Risk Factors for Early Myocardial Infarction in South Asians Compared With Individuals in Other Countries
    2007 722 citations Sumathy Rangarajan, Salim Yusuf et al. profile →
  44. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study
    2006 720 citations Koon Teo, Rafael Díaz et al. profile →
  45. Randomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy
    2015 719 citations Álvaro Avezum, Janice Pogue et al. profile →
  46. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial
    2008 709 citations Salim Yusuf, Janice Pogue et al. profile →
  47. Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-53.
    2000 695 citations Salim Yusuf et al. profile →
  48. Cardiovascular sequelae of preeclampsia/eclampsia: A systematic review and meta-analyses
    2008 676 citations Salim Yusuf et al. profile →
  49. Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure
    1999 662 citations Robert S. McKelvie, Salim Yusuf et al. Circulation profile →
  50. Analysis and Interpretation of Treatment Effects in Subgroups of Patients in Randomized Clinical Trials
    1991 643 citations Salim Yusuf profile →
  51. Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range
    2008 640 citations Stuart J. Connolly, Janice Pogue et al. Circulation profile →
  52. Cardiovascular Complications of Cancer Therapy
    2004 632 citations Salim Yusuf et al. Circulation profile →
  53. The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients
    2013 630 citations Paul Reilly, Stuart J. Connolly et al. profile →
  54. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study
    2008 622 citations Rafael Díaz, Sumathy Rangarajan et al. profile →
  55. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study
    2008 617 citations Jeffrey L. Probstfield, Salim Yusuf et al. profile →
  56. Influence of Ejection Fraction on Cardiovascular Outcomes in a Broad Spectrum of Heart Failure Patients
    2005 609 citations Scott D. Solomon, Hicham Skali et al. Circulation profile →
  57. Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome
    2004 598 citations Salim Yusuf et al. Circulation profile →
  58. Early versus Delayed Invasive Intervention in Acute Coronary Syndromes
    2009 582 citations Christopher B. Granger, Álvaro Avezum et al. profile →
  59. Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction
    2000 570 citations Salim Yusuf, Andrzej Budaj et al. Circulation profile →
  60. Prevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
    2005 564 citations Jeff S. Healey, Salim Yusuf et al. profile →
  61. Effects of Ramipril and Vitamin E on Atherosclerosis
    2001 534 citations Eva Lonn, Salim Yusuf et al. Circulation profile →
  62. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study
    2003 531 citations Salim Yusuf et al. profile →
  63. Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes
    2005 515 citations Lars Wallentin, Salim Yusuf et al. profile →
  64. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme
    2008 503 citations Mark C. Petrie, Jan Östergren et al. profile →
  65. Association of Diet, Exercise, and Smoking Modification With Risk of Early Cardiovascular Events After Acute Coronary Syndromes
    2010 492 citations Salim Yusuf et al. Circulation profile →
  66. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions
    1992 489 citations Salim Yusuf et al. profile →
  67. Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure
    2007 457 citations Scott D. Solomon, Joanna Dobson et al. Circulation profile →
  68. Urinary Sodium and Potassium Excretion and Risk of Cardiovascular Events
    2011 425 citations Martin O’Donnell, Salim Yusuf et al. profile →
  69. Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin
    2012 399 citations Jeff S. Healey, John W. Eikelboom et al. Circulation profile →
  70. Food Consumption and its Impact on Cardiovascular Disease: Importance of Solutions Focused on the Globalized Food System
    2015 362 citations Andrew Mente, Salim Yusuf et al. profile →
  71. Saturated Fats and Health: A Reassessment and Proposal for Food-Based Recommendations
    2020 360 citations Andrew Mente, Salim Yusuf et al. profile →
  72. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study
    2016 330 citations Ziad Hijazi, Jonas Oldgren et al. profile →
  73. Reducing the Global Burden of Cardiovascular Disease, Part 2
    2017 286 citations Koon Teo, Salim Yusuf et al. profile →
  74. Heart Failure with Mid-Range Ejection Fraction in CHARM: Characteristics, Outcomes and Effect of Candesartan Across the Entire Ejection Fraction Spectrum
    2018 276 citations Pardeep S. Jhund, Karl Swedberg et al. European Journal of Heart Failure profile →
  75. Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease
    2018 269 citations John W. Eikelboom, Stuart J. Connolly et al. profile →
  76. Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic Groups
    2019 212 citations Salim Yusuf et al. Circulation profile →

Peers

Salim Yusuf
Comparison fields: 5 of 229
  • Cardiology and Cardiovascular Medicine 103.5k
  • Surgery 28.9k
  • Endocrinology, Diabetes and Metabolism 24.4k
  • Internal Medicine 16.4k
  • Epidemiology 15.1k
Replace Deepak L. Bhatt with:
Deepak L. Bhatt United States
Gregg C. Fonarow United States
Stuart Pocock United Kingdom
Daniel Levy United States
William B. Kannel United States
Eric D. Peterson United States
Gordon Guyatt Canada
Harlan M. Krumholz United States
Emelia J. Benjamin United States
Gregory Y.H. Lip United Kingdom
Salim Yusuf relative to Deepak L. Bhatt United States Deepak L. Bhatt's profile →
Citations per field
00.5×1.5×1.8×
Deepak L. Bhatt · 1×
Citations per year

Countries citing papers authored by Salim Yusuf

Since Specialization
Citations

This map shows the geographic impact of Salim Yusuf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salim Yusuf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salim Yusuf more than expected).

Fields of papers citing papers by Salim Yusuf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salim Yusuf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salim Yusuf. The network helps show where Salim Yusuf may publish in the future.

Co-authorship network of co-authors of Salim Yusuf

This figure shows the co-authorship network connecting the top 25 collaborators of Salim Yusuf. A scholar is included among the top collaborators of Salim Yusuf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salim Yusuf. Salim Yusuf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1
Bariatric Surgery and Cardiovascular Outcomes in Patients With Obesity and Cardiovascular Disease:
2021 ·Circulation ·Aristithes G. Doumouras,Jorge Wong,J. Michael Paterson,Yung Lee,Branavan Sivapathasundaram,Jean‐Éric Tarride,Lehana Thabane,(unknown),Salim Yusuf,Mehran Anvari
123
2
Associations of household solid fuel for heating and cooking with hypertension in Chinese adults
2020 ·Journal of Hypertension ·Zhiguang Liu,Perry Hystad,Yuqing Zhang,Sumathy Rangarajan,Lu Yin,Yang Wang,Bo Hu,Fanghong Lu,(unknown),Yindong Li,Shrikant I. Bangdiwala,Salim Yusuf,Wei Li,Lap Ah Tse
20
3
Population attributable fractions for continuously distributed exposures
2020 ·John Ferguson,Fabrizio Maturo,Salim Yusuf,Martin O’Donnell
10
4
Primary Prevention With Statin Therapy in the Elderly
2017 ·Circulation ·Paul M. Ridker,Eva Lonn,Nina P. Paynter,Robert J. Glynn,Salim Yusuf
89
5
Physical Activity and Anger or Emotional Upset as Triggers of Acute Myocardial Infarction
2016 ·Circulation ·Andrew Smyth,Martin O’Donnell,Pablo Lamelas,Koon Teo,Sumathy Rangarajan,Salim Yusuf
96
6
Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme
2015 ·European Journal of Heart Failure ·(unknown),Ana Cristina Perez Moreno,Nathaniel M. Hawkins,Alan Brunton,Pardeep S. Jhund,Chih Wong,Scott D. Solomon,Christopher B. Granger,Salim Yusuf,Marc A. Pfeffer,Karl Swedberg,Roy S. Gardner,Mark C. Petrie,John J.V. McMurray
13
7
Causes of Death and Influencing Factors in Patients With Atrial Fibrillation
2013 ·Circulation ·Éloi Marijon,Jean‐Yves Le Heuzey,Stuart J. Connolly,Sean Yang,Janice Pogue,Martina Brueckmann,John W. Eikelboom,Ellison Themeles,Michael D. Ezekowitz,Lars Wallentin,Salim Yusuf
226
8
Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin
2013 ·Circulation ·Ammar Majeed,Hun-Gyu Hwang,Stuart J. Connolly,John W. Eikelboom,Michael D. Ezekowitz,Lars Wallentin,Martina Brueckmann,Mandy Fraessdorf,Salim Yusuf,Sam Schulman
209
9
Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarinbreakdown →
2012 ·Circulation ·Jeff S. Healey,John W. Eikelboom,James D. Douketis,Lars Wallentin,Jonas Oldgren,Sean Yang,Ellison Themeles,Hein Heidbüchel,Álvaro Avezum,Paul Reilly,Stuart J. Connolly,Salim Yusuf,Michael D. Ezekowitz
399
10
Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran
2012 ·Stroke ·Robert G. Hart,Hans‐Christoph Diener,Sean Yang,Stuart J. Connolly,Lars Wallentin,Paul Reilly,Michael D. Ezekowitz,Salim Yusuf
313
11
Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial
2012 ·Circulation ·Antonio L. Dans,Stuart J. Connolly,Lars Wallentin,Sean Yang,Juliet Nakamya,Martina Brueckmann,Michael D. Ezekowitz,Jonas Oldgren,John W. Eikelboom,Paul Reilly,Salim Yusuf
344
12
Relationship Between Healthy Diet and Risk of Cardiovascular Disease Among Patients on Drug Therapies for Secondary Prevention
2012 ·Circulation ·Mahshid Dehghan,Andrew Mente,Koon Teo,Peggy Gao,Peter Sleight,Gilles R. Dagenais,Álvaro Avezum,Jeffrey L. Probstfield,(unknown),Salim Yusuf
122
13
Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin
2012 ·Stroke ·Greg C. Flaker,John W. Eikelboom,Olga Shestakovska,Stuart J. Connolly,Scott Kaatz,Andrzej Budaj,Steen Husted,Salim Yusuf,Gregory Y.H. Lip,Robert G. Hart
61
14
Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation
2012 ·Circulation ·Ziad Hijazi,Jonas Oldgren,Ulrika Andersson,Stuart J. Connolly,Michael D. Ezekowitz,Stefan H. Hohnloser,Paul Reilly,Dragoş Vinereanu,Agneta Siegbahn,Salim Yusuf,Lars Wallentin
304
15
Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries
2012 ·Circulation ·Harriette G.C. Van Spall,Lars Wallentin,Salim Yusuf,John W. Eikelboom,Robby Nieuwlaat,Sean Yang,Conrad Kabali,Paul Reilly,Michael D. Ezekowitz,Stuart J. Connolly
112
16
Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)
2011 ·Circulation ·Giuseppe Mancia,Helmut Schumacher,Josep Redón,Paolo Verdecchia,Roland E. Schmieder,Garry Jennings,Khalid Yusoff,Lars Rydén,(unknown),Koon Teo,Peter Sleight,Salim Yusuf
115
17
Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both
2010 ·Circulation ·Michael Böhm,Magnus Baumhäkel,Koon Teo,Peter Sleight,Jeffrey L. Probstfield,Peggy Gao,Johannes F.E. Mann,Rafael Díaz,Gilles R. Dagenais,Garry Jennings,Lisheng Liu,Petr Janský,Salim Yusuf
132
18
Prevalence and Prognostic Impact of Bundle Branch Block in Patients with Heart Failure: Evidence from the CHARM Programme
2007 ·European Journal of Heart Failure ·Nathaniel M. Hawkins,Duolao Wang,John J.V. McMurray,Marc A. Pfeffer,Karl Swedberg,Christopher B. Granger,Salim Yusuf,Stuart Pocock,Jan Östergren,Eric L. Michelson,Francis G. Dunn
45
19
Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failurebreakdown →
2007 ·Circulation ·Scott D. Solomon,Joanna Dobson,Stuart Pocock,Hicham Skali,John J.V. McMurray,Christopher B. Granger,Salim Yusuf,Karl Swedberg,James B. Young,Eric L. Michelson,Marc A. Pfeffer
457
20
Characterization of Health-Related Quality of Life in Heart Failure Patients with Preserved Versus Low Ejection Fraction in CHARM
2006 ·European Journal of Heart Failure ·Eldrin F. Lewis,Gervasio A. Lamas,Eileen O’Meara,Christopher B. Granger,Mark E. Dunlap,Robert S. McKelvie,Jeffrey L. Probstfield,James B. Young,Eric L. Michelson,Katarina Halling,Jonas Carlsson,Bertil Olofsson,John J.V. McMurray,Salim Yusuf,Karl Swedberg,Marc A. Pfeffer,(unknown)
179

About Salim Yusuf

Salim Yusuf is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Family Practice, having authored 1.3k papers that have together received 157.0k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (209 papers), Heart Failure Treatment and Management (193 papers) and Blood Pressure and Hypertension Studies (189 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (103.5k citations), Internal Medicine (16.4k citations) and Endocrinology, Diabetes and Metabolism (24.4k citations). Salim Yusuf has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Sonia S. Anand, Stephanie Ôunpuu, Hertzel C. Gerstein, John W. Eikelboom, Shamir R. Mehta, John J.V. McMurray, Marc A. Pfeffer, Stuart J. Connolly, Karl Swedberg and Janice Pogue. Their work appears in journals such as New England Journal of Medicine, The Lancet and Physical Review Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deepak L. BhattBreakdown of academic impact, for papers by Gregg C. FonarowBreakdown of academic impact, for papers by Stuart PocockBreakdown of academic impact, for papers by Daniel LevyBreakdown of academic impact, for papers by William B. KannelBreakdown of academic impact, for papers by Eric D. PetersonBreakdown of academic impact, for papers by Gordon GuyattBreakdown of academic impact, for papers by Harlan M. KrumholzBreakdown of academic impact, for papers by Emelia J. BenjaminBreakdown of academic impact, for papers by Gregory Y.H. Lip
Rankless by CCL
2026